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Dear Editor,
In light of new ﬁndings, a small adjustment should be made
in our understanding of the relationship between Mcl-1 and
ABT-263/737.
ABT-263 and ABT-737 (ABT) are Bcl-2 antagonists that
bind to Bcl-2 family members with high afﬁnity, but do not
bind to Mcl-1. As single agents, they induce apoptosis in
lymphomas and small cell lung carcinomas with varied
efﬁcacy. In an attempt to explain this varied efﬁcacy, it has
been suggested that the presence of Mcl-1 protein is
hindering the apoptosis-inducing power of these agents.
1,2
Indeed, in numerous studies, the Mcl-1 expression levels
inversely correlated with sensitivity to ABT-737 in small
lymphomas and cell lung carcinomas with a few notable
exceptions. One of the exceptions is a promyerlocytic
leukemia cell line, HL-60. These cells express reasonably
large amounts of Mcl-1, but they are nevertheless sensitive
to ABT-737.
3 In most cells, Bak is normally sequestered by
Mcl-1 and Bcl-xL, and only when Bak is freed from both, can it
induce apoptosis.
4 In HL-60 cells, however, Mcl-1 does not
co-precipitate with Bak, suggesting that the real determinant
of ABT sensitivity is how much Bak is sequestered in its
association with Mcl-1, and not the presence of Mcl-1 protein
per se. Interestingly, we found that the strength of this
association can be weakened without lowering the Mcl-1
expression levels by pre-incubating cancer cells with deoxy-
glucose for only 1–3h.
5 Unlike apoptosis induced by glucose
depletion,
6–8 during the short time that it took deoxyglucose to
prime cells for apoptosis, similar amounts of Mcl-1 remained.
However, we could no longer co-precipitate Mcl-1 with Bak,
and the sensitivity of these cells to ABT increased by 10-fold.
A short exposure to deoxyglucose sensitizes all sorts of
cancer cells for ABT-induced apoptosis.
5 It can also induce
apoptosis in untransformed cells such as NIH3T3 cells if they
become highly glycolytic by culture conditions, suggesting
that deoxyglucose can prime even normal healthy cells if they
become highly glycolytic. Besides cancer cells, some brain
cells are known to be highly glycolytic. However, because
ABTdoesnotcross theblood–brainbarrier,inanimalstreated
with the deoxyglucose and ABT combination, the only cells
exposed to both agents would be highly glycolytic cancer
cells outside the brain. Indeed, in our experiments using
cancer-bearing mice, the deoxyglucose-ABT-263 combina-
tion effectively treated tumor cells located outside the brain,
with very little harm to the animals.
5
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